Consumer Health - Synchrony's earnings suggest the U S consumer is "in pretty good shape"[1] - The U S consumer's financial well-being is contingent on inflation not spiking[1]

[PART I - FINANCIAL INFORMATION](index=6&type=section&id=PART%20I%20-%20FINANCIAL%20INFORMATION) This section provides a comprehensive overview of Synchrony Financial's financial performance, condition, liquidity, and capital for the reporting period [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=6&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Synchrony Financial's Q2 2025 net earnings increased to $967 million due to lower credit loss provisions, alongside improved credit quality and key partnership extensions Q2 & Six-Month 2025 vs 2024 Performance Highlights | Metric | Q2 2025 | Q2 2024 | Change | 6M 2025 | 6M 2024 | Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | **Net Earnings** | $967M | $643M | +50.4% | $1.7B | $1.9B | -10.5% | | **Loan Receivables (Period-End)** | $99.8B | $102.3B | -2.5% | $99.8B | $102.3B | -2.5% | | **Net Interest Income** | $4.5B | $4.4B | +2.6% | $9.0B | $8.8B | +2.0% | | **Provision for Credit Losses** | $1,146M | $1,691M | -32.2% | $2,637M | $3,575M | -26.2% | | **Net Charge-off Rate** | 5.70% | 6.42% | -72 bps | 6.04% | 6.37% | -33 bps | | **30+ Day Delinquency Rate** | 4.18% | 4.47% | -29 bps | 4.18% | 4.47% | -29 bps | [Introduction and Business Overview](index=6&type=section&id=Introduction%20and%20Business%20Overview) Synchrony is a consumer financial services company managing $99.8 billion in loan receivables across five sales platforms, with credit cards comprising 92.2% of its portfolio - The company operates through **five sales platforms**: Home & Auto, Digital, Diversified & Value, Health & Wellness, and Lifestyle[21](index=21&type=chunk) Credit Product Mix as of June 30, 2025 | Credit Product | Standard Terms Only | Deferred Interest | Other Promotional | Total | | :--- | :--- | :--- | :--- | :--- | | **Credit cards** | 61.4% | 18.0% | 12.8% | **92.2%** | | **Commercial credit products** | 2.0% | — | — | **2.0%** | | **Consumer installment loans** | — | 0.2% | 5.5% | **5.7%** | | **Other** | 0.1% | — | — | **0.1%** | | **Total** | **63.5%** | **18.2%** | **18.3%** | **100.0%** | [Business Trends and Conditions](index=9&type=section&id=Business%20Trends%20and%20Conditions) The vacating of the CFPB's late fee rule and the extension of the Amazon program agreement enhance regulatory clarity and long-term partnership stability for Synchrony - The CFPB's final rule on credit card late fees, which would have lowered the safe harbor amount to $8, was **vacated by a court on April 15, 2025**[36](index=36&type=chunk)[37](index=37&type=chunk)[38](index=38&type=chunk) - The company extended its program agreement with Amazon in July 2025, with agreements for its **five largest partners now expiring between 2030 and 2035**[39](index=39&type=chunk) [Results of Operations](index=12&type=section&id=Results%20of%20Operations) Q2 2025 net earnings increased 50.4% to $967 million due to lower credit loss provisions, while six-month net earnings decreased 10.5% to $1.7 billion, impacted by a prior-year gain Summary Earnings (in millions) | | Three months ended June 30, | Six months ended June 30, | | :--- | :--- | :--- | :--- | :--- | | **($ in millions)** | **2025** | **2024** | **2025** | **2024** | | Net interest income | $4,521 | $4,405 | $8,985 | $8,810 | | Retailer share arrangements | $(992) | $(810) | $(1,887) | $(1,574) | | Provision for credit losses | $1,146 | $1,691 | $2,637 | $3,575 | | Other income | $118 | $117 | $267 | $1,274 | | Other expense | $1,245 | $1,177 | $2,488 | $2,383 | | **Net earnings** | **$967** | **$643** | **$1,724** | **$1,936** | - Provision for credit losses decreased significantly, driven by **reserve releases of $265 million in Q2 2025** compared to a reserve build of $70 million in Q2 2024, as well as lower net charge-offs[72](index=72&type=chunk) - Retailer share arrangements increased by **22.5% in Q2 2025**, reflecting lower net charge-offs and the impact of product, pricing, and policy changes[71](index=71&type=chunk) [Platform Analysis](index=19&type=section&id=Platform%20Analysis) Q2 2025 platform performance showed varied results, with Digital platform interest and fees growing 2.1% to $1.6 billion, while Home & Auto interest and fees decreased 1.0% to $1.4 billion Purchase Volume by Platform (Q2 2025 vs Q2 2024, in millions) | Platform | Q2 2025 | Q2 2024 | % Change | | :--- | :--- | :--- | :--- | | Home & Auto | $11,459 | $12,350 | -7.2% | | Digital | $13,647 | $13,403 | +1.8% | | Diversified & Value | $15,393 | $15,333 | +0.4% | | Health & Wellness | $4,007 | $4,089 | -2.0% | | Lifestyle | $1,432 | $1,525 | -6.1% | Interest and Fees on Loans by Platform (Q2 2025 vs Q2 2024, in millions) | Platform | Q2 2025 | Q2 2024 | % Change | | :--- | :--- | :--- | :--- | | Home & Auto | $1,395 | $1,409 | -1.0% | | Digital | $1,576 | $1,544 | +2.1% | | Diversified & Value | $1,159 | $1,165 | -0.5% | | Health & Wellness | $923 | $911 | +1.3% | | Lifestyle | $261 | $258 | +1.2% | [Financial Condition, Liquidity and Capital](index=22&type=section&id=Financial%20Condition,%20Liquidity%20and%20Capital) Synchrony's financial condition remains strong with $99.8 billion in loan receivables, improved credit quality, robust liquidity of $21.8 billion, and a CET1 ratio of 13.6% - Over-30 day loan delinquencies as a percentage of period-end loan receivables decreased to **4.18% at June 30, 2025**, from 4.47% at June 30, 2024[104](index=104&type=chunk) - The company maintains a strong liquidity portfolio of **$21.8 billion in liquid assets** as of June 30, 2025, up from $17.2 billion at year-end 2024[138](index=138&type=chunk) Regulatory Capital Ratios (Synchrony Financial) | Ratio | At June 30, 2025 | At December 31, 2024 | | :--- | :--- | :--- | | **Common equity Tier 1 capital** | 13.6% | 13.3% | | **Tier 1 risk-based capital** | 14.8% | 14.5% | | **Total risk-based capital** | 16.9% | 16.5% | | **Tier 1 leverage** | 12.7% | 12.9% | [Critical Accounting Estimates](index=32&type=section&id=Critical%20Accounting%20Estimates) Synchrony updated its Allowance for Credit Losses methodology in Q1 2025 to a statistical, account-level model, enhancing loss estimation without material impact, maintaining a 12-month forecast period - In Q1 2025, the company changed its methodology for the Allowance for Credit Losses to a **statistical, account-level model** analyzing probability of default and exposure at default, replacing the prior enhanced migration analysis[162](index=162&type=chunk) - The reasonable and supportable forecast period for estimating expected credit losses remains at **12 months**, after which the company reverts to historical loss information over a 6-month period on a straight-line basis[168](index=168&type=chunk) [Financial Statements](index=35&type=section&id=Item%201.%20Financial%20Statements) This section provides unaudited condensed consolidated financial statements for Q2 and six months ended June 30, 2025, including core statements and detailed notes on accounting policies, credit losses, and regulatory capital [Condensed Consolidated Financial Statements](index=36&type=section&id=Condensed%20Consolidated%20Financial%20Statements) The unaudited condensed consolidated financial statements show Q2 2025 net income of $967 million, total assets of $120.5 billion, and $4.8 billion cash from operations for the first six months - The report includes the following unaudited statements: Condensed Consolidated Statements of Earnings, Comprehensive Income, Financial Position, Changes in Equity, and Cash Flows[180](index=180&type=chunk) [Notes to Condensed Consolidated Financial Statements](index=43&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Notes to financial statements detail a decrease in allowance for credit losses to $10.6 billion, $16.0 billion in total borrowings, and confirm strong regulatory capital ratios, with no material adverse legal matters Allowance for Credit Losses Roll-Forward (Six Months Ended June 30, 2025, in millions) | | Credit cards | Consumer installment loans | Commercial credit products | Total | | :--- | :--- | :--- | :--- | :--- | | **Balance at Jan 1, 2025** | $10,259 | $542 | $127 | **$10,929** | | Provision charged to operations | $2,413 | $173 | $48 | **$2,634** | | Gross charge-offs | $(3,496) | $(202) | $(68) | **$(3,766)** | | Recoveries | $730 | $32 | $5 | **$767** | | **Balance at June 30, 2025** | **$9,906** | **$545** | **$112** | **$10,564** | - As of June 30, 2025, total borrowings were **$16.0 billion**, consisting of $8.3 billion from consolidated securitization entities and $7.7 billion in senior and subordinated unsecured notes[277](index=277&type=chunk) - Synchrony Bank's **CET1 ratio was 14.3%** at June 30, 2025, well above the 6.5% minimum required to be considered well-capitalized[302](index=302&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=66&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) Synchrony's primary market risk is interest rate risk, with a 100 basis point rate increase projected to boost net interest income by $73 million, while a decrease would reduce it by $164 million Net Interest Income Sensitivity (Next 12 Months) | Basis Point Change | Impact at June 30, 2025 (in millions) | | :--- | :--- | | -100 basis points | $(164) | | +100 basis points | $73 | [Controls and Procedures](index=66&type=section&id=Item%204.%20Controls%20and%20Procedures) The CEO and CFO concluded that disclosure controls and procedures were effective as of June 30, 2025, with no material changes to internal control over financial reporting - The CEO and CFO concluded that the company's **disclosure controls and procedures were effective** as of June 30, 2025[327](index=327&type=chunk) [PART II - OTHER INFORMATION](index=67&type=section&id=PART%20II%20-%20OTHER%20INFORMATION) This section details legal proceedings, risk factors, equity security sales, and other required disclosures [Legal Proceedings](index=67&type=section&id=Item%201.%20Legal%20Proceedings) Synchrony is involved in routine legal and regulatory matters, none of which are expected to have a material adverse effect on its financial condition or liquidity - The company does not believe it is a party to any pending legal or regulatory matters that would have a **material adverse effect** on its condensed consolidated financial condition or liquidity[320](index=320&type=chunk) [Risk Factors](index=67&type=section&id=Item%201A.%20Risk%20Factors) No material changes to the risk factors previously disclosed in the 2024 Annual Report on Form 10-K were reported - No **material changes to the risk factors** from the 2024 Form 10-K were reported[331](index=331&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=67&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) Synchrony repurchased 8.8 million shares for $500 million in Q2 2025 and approved a new $2.5 billion share repurchase program through June 2026, with $2.0 billion remaining Share Repurchases for Q2 2025 | Period | Total Shares Purchased | Average Price Paid Per Share | Dollar Value (in millions) | | :--- | :--- | :--- | :--- | | April 1 - 30, 2025 | 1,963,034 | $51.70 | ~$98.7 | | May 1 - 31, 2025 | 5,260,066 | $56.98 | ~$299.7 | | June 1 - 30, 2025 | 1,654,690 | $61.48 | ~$101.7 | | **Total Q2 2025** | **8,877,790** | **$56.32** | **$500.0** | - In April 2025, the Board approved a new share repurchase program of up to **$2.5 billion through June 30, 2026**, with $2.0 billion remaining authorized for repurchase at the end of Q2 2025[334](index=334&type=chunk)[148](index=148&type=chunk) [Other Part II Items](index=67&type=section&id=Other%20Part%20II%20Items) This section confirms no defaults on senior securities, no applicable mine safety disclosures, and no Rule 10b5-1 trading plan changes by directors or officers - Item 3: No defaults upon senior securities[335](index=335&type=chunk) - Item 5: No directors or officers adopted, modified, or terminated a **Rule 10b5-1 trading arrangement** during the quarter[338](index=338&type=chunk)

Credit Card Giant Synchrony's Earnings Show U.S. Consumer “In Pretty Good Shape”–As Long As Inflation Doesn't Spike https://t.co/VwADHg0RN9 https://t.co/VwADHg0RN9 ...

Core Insights - Synchrony has announced a strategic partnership with Dental Intelligence to integrate CareCredit financing options into their patient relationship management platform, enhancing administrative efficiency for dental practices [1][2]. Partnership Details - The integration will allow dental practices to manage patient financing more intuitively through automated payment communications, including appointment reminders and confirmations [3][4]. - This collaboration aims to simplify financial discussions within dental practices, making it easier for patients to understand their payment options [4][5]. Benefits for Providers and Patients - Providers will have the ability to identify if patients are preapproved for CareCredit, streamlining the financing process throughout the care journey [4]. - The partnership is expected to enhance patient-provider relationships and improve operational efficiency for clinical staff [5]. Company Background - Synchrony has been a leader in consumer lending for nearly 100 years and has specialized in dental financing with CareCredit for over 35 years, accepted by more than 285,000 providers, including 80% of dental practices in the U.S. [6].

RT Jeff Kauflin (@JeffKauflin)New: Credit card giant Synchrony’s earnings show that the U.S. consumer is “in pretty good shape”—as long as inflation doesn’t spike: https://t.co/AxTVgSKb1S ...

Credit Card Giant Synchrony's Earnings Show U.S. Consumer “In Pretty Good Shape”–As Long As Inflation Doesn't Spikehttps://t.co/9rY8X5BICZ https://t.co/4Z5GGqEgp7 ...

Core Viewpoint - Synchrony Financial (NYSE: SYF) has shown significant stock performance, returning over 38% since the last quarter, outperforming the S&P 500 which returned around 17% [1] Company Performance - The stock of Synchrony Financial has appreciated significantly, indicating strong market confidence and performance [1] Investment Strategy - The investment approach focuses on long-term holdings, seeking opportunities regardless of asset class, market cap, sector, or yield, with an emphasis on maximizing total return by purchasing when prices are low relative to intrinsic value [1]

Core Insights - Synchrony Financial (SYF) reported strong second-quarter 2025 results with adjusted earnings per share (EPS) of $2.50, exceeding the Zacks Consensus Estimate by 45.4% and reflecting a year-over-year increase of 61.3% [1][9] - The company's net interest income reached $4.5 billion, a 2.6% year-over-year growth, surpassing the consensus estimate by 0.5% [1][2] Financial Performance - Improved net interest margin and increased interest and fees on loans contributed to the strong quarterly results, alongside a reduced provision for credit losses [2][9] - Total loan receivables decreased by 2.5% year over year to $99.8 billion, missing the Zacks Consensus Estimate of $100.9 billion [3][4] - Total deposits fell by 1% year over year to $82.3 billion, also below the estimate of $83.9 billion [4] - Provision for credit losses was $1.1 billion, down 32.2% year over year, which was lower than the estimate of $1.7 billion [4][9] Segment Performance - Retailer share arrangements increased by 22% year over year to $992 million [3] - Home & Auto loan receivables decreased by 6.9% year over year, while Digital loan receivables inched up by 0.3% [7][10] - Health & Wellness loan receivables saw a slight increase of 0.2% year over year, but purchase volume fell by 2% [10] Financial Position - As of June 30, 2025, Synchrony had cash and equivalents of $19.5 billion, up from $14.7 billion at the end of 2024 [11] - Total assets increased to $120.1 billion from $119.5 billion at the end of 2024, with total equity rising to $17 billion [11][12] - The efficiency ratio improved to 34.1%, better than the consensus mark of 32.5% [6] Capital Deployment - Synchrony returned $500 million through share buybacks and paid $114 million in common stock dividends during the second quarter [13] - The company had approximately $2 billion remaining under its share buyback authorization as of June 30, 2025 [13] Guidance - For 2025, Synchrony anticipates flat loan receivables and slower purchase volume growth due to credit actions and consumer spending behavior [14] - Net revenues are projected to be between $15 billion and $15.3 billion, lower than the previous estimate of $15.2-$15.7 billion [14] - Management expects net charge-offs to be between 5.6% and 5.8%, with an efficiency ratio forecasted to remain between 32% and 33% [15]

Core Viewpoint - Synchrony Financial (NYSE: SYF) has shown strong performance over the past year, with a 37% increase in share price, despite concerns regarding the consumer credit environment not materializing [1] Group 1: Company Performance - The company reported extremely strong results, indicating resilience in its operations and financial health [1] Group 2: Market Context - The fears surrounding a worsening consumer credit environment have not been realized, contributing to the positive performance of Synchrony Financial [1]

Core Insights - Synchrony reported revenue of $4.52 billion for the quarter ended June 2025, reflecting a year-over-year increase of 2.6% and a surprise of +0.46% over the Zacks Consensus Estimate of $4.5 billion [1] - Earnings per share (EPS) reached $2.50, significantly higher than the $1.55 reported in the same quarter last year, resulting in an EPS surprise of +45.35% compared to the consensus estimate of $1.72 [1] Financial Performance Metrics - Efficiency Ratio was reported at 34.1%, exceeding the average estimate of 32.5% by five analysts [4] - Net interest margin stood at 14.8%, slightly above the estimated 14.5% by five analysts [4] - Net charge-offs as a percentage of average loan receivables were 5.7%, better than the three-analyst average estimate of 6% [4] - Total period-end loan receivables amounted to $99.78 billion, lower than the three-analyst average estimate of $100.94 billion [4] - Total average loan receivables, including those held for sale, were $99.24 billion, compared to the three-analyst average estimate of $100.04 billion [4] - Total interest-earning assets average balance was $122.71 billion, below the three-analyst average estimate of $125.6 billion [4] Platform Analysis - Digital platform period-end loan receivables were $27.79 billion, slightly below the two-analyst average estimate of $27.91 billion [4] - Home & Auto platform average loan receivables, including those held for sale, were $30.14 billion, compared to the two-analyst average estimate of $31.05 billion [4] - Diversified & Value platform purchase volume reached $15.39 billion, exceeding the estimated $15.15 billion by two analysts [4] - Diversified & Value platform period-end loan receivables were $19.51 billion, slightly below the average estimate of $19.59 billion based on two analysts [4] - Health & Wellness platform purchase volume was $4.01 billion, surpassing the average estimate of $3.96 billion based on two analysts [4] Stock Performance - Synchrony shares have returned +9.8% over the past month, outperforming the Zacks S&P 500 composite's +5.9% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]